Research in focus: Antimicrobial resistance in cystic fibrosis
In October 2020 the Cystic Fibrosis Trust published a research in focus report on antimicrobial resistance (AMR) in cystic fibrosis. While AMR is a concern for us all, people living with CF are particularly vulnerable to it. The report highlights how CF researchers are leading the way in tackling AMR in CF, and how the ground-breaking approaches described in this report will be beneficial for people with CF in the future. Innovations made in tackling AMR in CF will also be applicable to solving AMR for all those with drug-resistant infections.
Boosting innovation to curb AMR?
AMR Innovation Mission UK 2021
The AMR Innovation Mission UK 2021 aims to add to the global curbing of AMR by boosting joint early & translational research, R&D, clinical development, validation, registration and commercialisation of vaccines, microbial diagnostics and antimicrobial products.